
Matthew Kurian/youtube.com
Sep 3, 2025, 07:48
Matthew Kurian: Registration is Open for Implications of HER2 Testing in Cancer Management Session
Matthew Kurian, Assistant Professor of Medicine at the University of Kentucky College of Medicine, shared a post on LinkedIn:
“Excited to partner with the Innovative Healthcare Institute (IHCI) and Cincinnati Cancer Advisors for an important discussion on the implications of HER2 testing in cancer.
I’ll be highlighting the evolving role of HER2 testing in breast cancer — from HER2+ to HER2-low and ultralow, and what that means for patient care.
My colleague Dr. Ben Kuritzky, TriHealth will discuss the expanding impact of HER2 across other solid tumors, including GI, lung, and more.
Don’t miss this session bringing together perspectives across tumor types.
RSVP today to secure your spot.”
More posts featuring Matthew Kurian on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 3, 2025, 07:37
Sep 3, 2025, 07:28
Sep 3, 2025, 07:14
Sep 3, 2025, 07:03
Sep 3, 2025, 06:38
Sep 3, 2025, 06:23
Sep 3, 2025, 05:47